CAIHF Stock Chart & Stats
$0.28
$0.00(0.00%)
At close: 4:00 PM EDT
$0.28
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.28 - $0.28
Previous CloseN/A
Volume79.00
Average Volume (3M)0.00
Market Cap
$290.12M
Enterprise Value$2.11K
Total Cash (Recent Filing)$37.34M
Total Debt (Recent Filing)$57.40M
Price to Earnings (P/E)9.7
Beta8.69
Next Earnings
Aug 11, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.12
Shares Outstanding240,718,300
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)0.85
Price to Sales (P/S)0.44
P/FCF Ratio8.42
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue Rebound & Improving MarginsA large revenue recovery with rising operating and net margins signals stronger underlying demand and better operating leverage. Sustained higher volumes and improved margins can raise cash generation, support reinvestment and build resilience against cyclical shocks over the next several quarters.
Conservative, Improving Balance SheetMaterial deleveraging and rising equity improve financial flexibility and lower refinancing and solvency risk. A conservative leverage profile increases capacity for capex or opportunistic investments and supports stability in earnings and operations across a multi‑month horizon.
Improved Cash Generation & FCF CoverageTransition to positive free cash flow with high coverage of net income indicates improving earnings quality and internal funding capacity. Consistent FCF enables working capital management, deleveraging or targeted reinvestment, reducing reliance on external financing over the medium term.
Bears Say
Earnings And Cash Flow VolatilityMulti-year swings in profitability and cash flow undermine predictability of returns and capital allocation. If the 2025 recovery proves cyclical rather than structural, the company could face renewed liquidity or financing stress, limiting sustained investment and stakeholder confidence.
Margin Compression Versus Prior YearsMaterial decline in gross margins suggests structural cost or pricing pressure—such as raw material inflation, product mix shift or competitive pricing—that reduces the ability of revenue growth to translate into durable profit expansion and constrains long‑term return on capital.
Modest OCF Relative To Sales / Working-capital DemandsLow cash conversion despite positive OCF means much revenue is tied up in working capital or reinvestment. Continued growth could require incremental funding or erode margins, limiting the durability of free cash flow and the company's ability to self-fund strategic initiatives.
Chia Tai Enterprises International News
CAIHF FAQ
What was Chia Tai Enterprises International Limited’s price range in the past 12 months?
Chia Tai Enterprises International Limited lowest stock price was $0.28 and its highest was $0.28 in the past 12 months.
What is Chia Tai Enterprises International Limited’s market cap?
Chia Tai Enterprises International Limited’s market cap is $290.12M.
When is Chia Tai Enterprises International Limited’s upcoming earnings report date?
Chia Tai Enterprises International Limited’s upcoming earnings report date is Aug 11, 2026 which is in 4 days.
How were Chia Tai Enterprises International Limited’s earnings last quarter?
Chia Tai Enterprises International Limited released its earnings results on May 12, 2026. The company reported $0.022 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Chia Tai Enterprises International Limited overvalued?
According to Wall Street analysts Chia Tai Enterprises International Limited’s price is currently Overvalued.
Does Chia Tai Enterprises International Limited pay dividends?
Chia Tai Enterprises International Limited does not currently pay dividends.
What is Chia Tai Enterprises International Limited’s EPS estimate?
Chia Tai Enterprises International Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Chia Tai Enterprises International Limited have?
Chia Tai Enterprises International Limited has 240,718,300 shares outstanding.
What happened to Chia Tai Enterprises International Limited’s price movement after its last earnings report?
Chia Tai Enterprises International Limited reported an EPS of $0.022 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Chia Tai Enterprises International Limited?
Currently, no hedge funds are holding shares in CAIHF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Chia Tai Enterprises International Limited
Chia Tai Enterprises International Limited primarily produces and distributes chlortetracycline (CTC) and related goods. Its extensive international reach covers Mainland China, the Asia Pacific region, the Americas, and Europe. The company's operations are divided into two distinct divisions: Biochemical and Industrial. The Biochemical division focuses on the manufacturing and supply of CTC premix and CTC hydrochloride products. These are employed as feed supplements to encourage livestock growth, prevent or cure animal illnesses, and improve feed conversion, sold under the brands Shihao and Citifac. Conversely, the Industrial segment handles the sales, rental, and maintenance of heavy construction machinery, encompassing items such as excavators, power generators, bulldozers, compactors, and their spare parts. This division also fabricates and markets carburetors and other automotive components for various automobile and motorcycle manufacturers. Founded in 1987, the company maintains its headquarters in Central, Hong Kong, and functions as a subsidiary of Charoen Pokphand Foods Public Company Limited.
Technical Analysis
The United Laboratories International Holdings
―
China Traditional Chinese Medicine Holdings Co
―
Wai Yuen Tong Medicine Holdings Limited
―
Lee's Pharmaceutical Holdings Limited
―
Grand Pharmaceutical Group Limited
―
Ownership Overview
―
Insiders
<0.01% Mutual Funds
― Other Institutional Investors
99.96% Public Companies and
Individual Investors